Stay Away from the Big Drug Stocks

Everyone knows about the troubles of Big Pharma. Last year, I said that I had more faith in Merck (MRK) rather than in Pfizer (PFE), although I wasn’t going to buy either.
Today, Pfizer lowered its earnings forecast for 2006. Wall Street was looking for $2.03 a share, but the company is only expecting $2 a share. Last year’s earnings came in at $2.02 a share.
Merck could be a good buy in a year or so, but I still wouldn’t touch either of these stocks.

Posted by on February 10th, 2006 at 2:50 pm


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.